Should the patentability examination of inventions be made under a specific test, or should it be part of the usual novelty and inventive step/non-obviousness test?

What are the key points necessary to build a high-quality, enforceable international patent portfolio? What is your experience in patent prosecution and litigation in the US and Asia?

These and other questions were answered yesterday during #IPBCEurope in Amsterdam among the panelists William Chelton (Dolby Laboratories), Antonio Lopez-Carrasco (Telefonica), Eva van Wanrooij (Nutreco) moderated by our Elio De Tullio ( De Tullio & Partners and INSME Board Member).

Share this content